Torts/Personal Injury
May 5, 2026
2nd talc bellwether trial opens against Johnson & Johnson
Opening statements highlight dispute over scientific evidence and internal company documents in ovarian cancer case.
The second bellwether ovarian cancer talc trial against Johnson & Johnson began Monday, focusing on claims brought by family members on behalf of three women who allege the company knew for decades its talc-based products posed a cancer risk but never warned consumers.
The first bellwether trial in the coordinated litigation before Superior Court Judge Theresa M. Traber ended last year in a $40 million verdict for two women and a spouse, a decision Johnson & Johnson has ap...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In